Adv Drug Deliv Rev

Adv Drug Deliv Rev

Country: Unknown

Publisher: Unknown

Publication Period: Unknown

55

Papers in Database

Journal Information
Publication Details
Additional Information

Subject Term Count: 1

Last Updated: Aug 05, 2025

Recent Papers

View All 55 Papers
Advances in mRNA therapeutics for cancer immunotherapy: From modification to delivery.

Han G, Noh D, Lee H, Lee S, Kim S, Yoon HY, Lee SH.

2023 PMID: 37369262
3/7
COI Funding
Imaging drug delivery to the lungs: Methods and applications in oncology.

Man F, Tang J, Swedrowska M, Forbes B, T M de Rosales R.

2022 PMID: 36509173
3/7
COI Funding
In vivo fate and intracellular trafficking of vaccine delivery systems.

Lee J, Kim D, Byun J, Wu Y, Park J, Oh YK.

2022 PMID: 35550392
3/7
COI Funding
Targeting the liver in dementia and cognitive impairment: Dietary macronutrients and diabetic therapeutics.

Hunt NJ, Wahl D, Westwood LJ, Lockwood GP, Le Couteur DG, Cogger VC.

2022 PMID: 36115494
3/7
COI Funding
Targeting vascular inflammation through emerging methods and drug carriers.

Nong J, Glassman PM, Muzykantov VR.

2022 PMID: 35271986
3/7
COI Funding
A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therape…

Rankin-Turner S, Vader P, O'Driscoll L, Giebel B, Heaney LM, Davies OG.

2021 PMID: 33862168
4/7
Data COI Funding
Adaptive immune responses to SARS-CoV-2.

Forthal D.

2021 PMID: 33610693
1/7
Advances in gene-based vaccine platforms to address the COVID-19 pandemic.

Pushparajah D, Jimenez S, Wong S, Alattas H, Nafissi N, Slavcev RA.

2021 PMID: 33422546
3/7
COI Funding